• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY Back to Search Results
Model Number 120602FP
Device Problem Contamination (1120)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
It was reported that the border between the catheter and the balloon seemed to be swollen and thicker than before.The customer did not want to use the catheter for concern of the possibility of damaging blood vessels during insertion.There were no patient complications reported.An unknown material detached during evaluation and was sent to chemistry for further analysis.The sample spectrum is consistent with that of zein (protein based material).
 
Manufacturer Narrative
One 120602f catheter was received for evaluation without any attached components.There was blood visible on balloon and windings.The reported issue of the catheter being swollen was confirmed.The proximal windings appeared thicker than known good lab sample.Furthermore, the proximal side of proximal windings was discolored.The catheter tube was bent at distal side of the hub.There was no other visible damage or abnormality observed from windings, balloon, and catheter body.The balloon inflated with 0.2 cc air as recommended in the ifu.The balloon inflated clear and concentric and did not leak.The catheter was sent for outer diameter (od) measurement.The outer diameter at the brown location was measured to be 0.0445" which was within specification.A review of the manufacturing records indicated that the product met specifications upon release.An unknown material detached during evaluation and was sent to chemistry for further analysis.The sample spectrum is consistent with that of zein (protein based material).Complaint histories for all reported events are reviewed against trending control limits on a monthly basis and any excursions above the control limits are assessed and documented as a part of the monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY ARTERIAL EMBOLECTOMY CATHETER
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco PR 00610
Manufacturer (Section G)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco PR 00610
Manufacturer Contact
samantha eveleigh
1 edwards way
irvine, CA 92614
9492503939
MDR Report Key13691099
MDR Text Key290145203
Report Number2015691-2022-04310
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
PREAMENDMEN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/10/2022
Device Model Number120602FP
Device Catalogue Number120602FP
Device Lot Number63325817
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/06/2022
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/08/2022
Initial Date FDA Received03/08/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-